GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer ; volume:10 ; number:1 ; day:30 ; month:7 ; year:2010 ; pages:1-13 ; date:12.2010
BMC cancer ; 10, Heft 1 (30.7.2010), 1-13, 12.2010
- Creator
-
Lynn, Kristi D.
- Contributor
-
Udugamasooriya, D Gomika
Roland, Christina L.
Castrillon, Diego H.
Kodadek, Thomas J.
Brekken, Rolf A.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-10-397
- URN
-
urn:nbn:de:1111-2016030361455
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lynn, Kristi D.
- Udugamasooriya, D Gomika
- Roland, Christina L.
- Castrillon, Diego H.
- Kodadek, Thomas J.
- Brekken, Rolf A.
- SpringerLink (Online service)
Other Objects (12)
PyPy status talk (a.k.a.: no no, PyPy is not dead)
PY
PY
Py
Consequences of VEGFR2 ablation during development
Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer
EuroSciPy 2017: SciPy
Comprehensive Analysis of VEGFR2 Expression in HPV-Positive and -Negative OPSCC Reveals Differing VEGFR2 Expression Patterns
The GIL is dead: PyPy-STM
PyPy meets Python 3 and Numpy
"Somme Py."
Prem... - Py...
PyPy status talk (a.k.a.: no no, PyPy is not dead)
PY
PY
Py
Consequences of VEGFR2 ablation during development
Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer
EuroSciPy 2017: SciPy
Comprehensive Analysis of VEGFR2 Expression in HPV-Positive and -Negative OPSCC Reveals Differing VEGFR2 Expression Patterns
The GIL is dead: PyPy-STM
PyPy meets Python 3 and Numpy
"Somme Py."
Prem... - Py...
PyPy status talk (a.k.a.: no no, PyPy is not dead)
PY
PY
Py
Consequences of VEGFR2 ablation during development
Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer
EuroSciPy 2017: SciPy
Comprehensive Analysis of VEGFR2 Expression in HPV-Positive and -Negative OPSCC Reveals Differing VEGFR2 Expression Patterns
The GIL is dead: PyPy-STM
PyPy meets Python 3 and Numpy
"Somme Py."